Advertisement

Topics

Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference

07:00 EDT 23 Oct 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
To Discuss UNITE Technology Application in Oncology Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, today announced that the company will present at the NYC Oncology Investor Confe...

Other Sources for this Article

Immunomic Therapeutics, Inc.
Sia Anagnostou, 717-327-1822

NEXT ARTICLE

More From BioPortfolio on "Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...